Sales rise 17.81% to Rs 483.10 crore
Net profit of Caplin Point Laboratories rose 13.87% to Rs 130.80 crore in the quarter ended September 2024 as against Rs 114.87 crore during the previous quarter ended September 2023. Sales rose 17.81% to Rs 483.10 crore in the quarter ended September 2024 as against Rs 410.06 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales483.10410.06 18 OPM %34.0833.51 -PBDT185.22157.76 17 PBT168.46146.00 15 NP130.80114.87 14Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content